0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Phenylketonuria (PKU) - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-347
Home | Category |Health |Health Conditions |Genetic Disorders
Phenylketonuria Epidemiology Forecast to 2028

Phenylketonuria (PKU) - Epidemiology Forecast to 2028

Code: DELV-Epid-347
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Phenylketonuria (PKU) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Phenylketonuria (PKU) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Phenylketonuria (PKU) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Phenylketonuria (PKU) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Phenylketonuria (PKU) outlook. It also includes the explanation of changing trends of epidemiology outlining the Phenylketonuria (PKU) scenario.

Phenylketonuria (PKU) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Phenylketonuria (PKU) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Phenylketonuria (PKU) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Phenylketonuria (PKU) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Phenylketonuria (PKU)

Key assessments
• Patient Segmentation in Phenylketonuria (PKU)
• Phenylketonuria (PKU) Risk & Burden
• Factors driving growth in a specific Phenylketonuria (PKU) patient population

1. Report Introduction
2. Phenylketonuria (PKU) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Phenylketonuria (PKU) in 2016
2.2. Patient Share Distribution of Phenylketonuria (PKU) in 2028
3. Disease Background and Overview: Phenylketonuria (PKU)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Phenylketonuria (PKU) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Phenylketonuria (PKU) in 7MM – By Countries
5. Epidemiology of Phenylketonuria (PKU) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.1.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.1.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.1.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.4.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.4.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.4.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.5.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.5.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.5.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.6.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.6.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.6.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.7.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.7.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.7.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.8.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.8.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.8.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.9.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.9.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.9.5. Diagnosed Cases of the Phenylketonuria (PKU)
6. Unmet Needs of the Phenylketonuria (PKU)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM
Table 2: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Phenylketonuria (PKU) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Phenylketonuria (PKU) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Phenylketonuria (PKU) in France (2016-2028) *
Table 14: Diagnosed Cases of the Phenylketonuria (PKU) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Phenylketonuria (PKU) in Japan (2016-2028)


LIst of Figures :

Figure 1: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Phenylketonuria (PKU) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Phenylketonuria (PKU) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Phenylketonuria (PKU) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Phenylketonuria (PKU) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Phenylketonuria (PKU) in Japan (2016-2028)

DelveInsight's "Phenylketonuria (PKU) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Phenylketonuria (PKU) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Phenylketonuria (PKU) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Phenylketonuria (PKU) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Phenylketonuria (PKU) outlook. It also includes the explanation of changing trends of epidemiology outlining the Phenylketonuria (PKU) scenario.

Phenylketonuria (PKU) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Phenylketonuria (PKU) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Phenylketonuria (PKU) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Phenylketonuria (PKU) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Phenylketonuria (PKU)

Key assessments
• Patient Segmentation in Phenylketonuria (PKU)
• Phenylketonuria (PKU) Risk & Burden
• Factors driving growth in a specific Phenylketonuria (PKU) patient population

Read More

1. Report Introduction
2. Phenylketonuria (PKU) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Phenylketonuria (PKU) in 2016
2.2. Patient Share Distribution of Phenylketonuria (PKU) in 2028
3. Disease Background and Overview: Phenylketonuria (PKU)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Phenylketonuria (PKU) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Phenylketonuria (PKU) in 7MM – By Countries
5. Epidemiology of Phenylketonuria (PKU) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.1.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.1.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.1.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.4.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.4.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.4.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.5.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.5.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.5.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.6.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.6.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.6.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.7.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.7.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.7.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.8.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.8.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.8.5. Diagnosed Cases of the Phenylketonuria (PKU)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Phenylketonuria (PKU)
5.9.3. Sub-Type Specific cases of the Phenylketonuria (PKU) *
5.9.4. Sex- Specific Cases of the Phenylketonuria (PKU) *
5.9.5. Diagnosed Cases of the Phenylketonuria (PKU)
6. Unmet Needs of the Phenylketonuria (PKU)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM
Table 2: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Phenylketonuria (PKU) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Phenylketonuria (PKU) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Phenylketonuria (PKU) in France (2016-2028) *
Table 14: Diagnosed Cases of the Phenylketonuria (PKU) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Phenylketonuria (PKU) in Japan (2016-2028)


LIst of Figures :

Figure 1: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Phenylketonuria (PKU) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Phenylketonuria (PKU) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Phenylketonuria (PKU) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Phenylketonuria (PKU) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Phenylketonuria (PKU) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Phenylketonuria (PKU) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Phenylketonuria (PKU) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Phenylketonuria (PKU) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Phenylketonuria (PKU) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Phenylketonuria (PKU) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Phenylketonuria (PKU) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Phenylketonuria (PKU) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Phenylketonuria (PKU) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Phenylketonuria (PKU) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Phenylketonuria (PKU) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Phenylketonuria (PKU) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Phenylketonuria (PKU) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Phenylketonuria (PKU) in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools
0 Items
X
No items in the cart.
$0.0